Robert Widmer, MD
Interventional Cardiology · Temple, TXNPI 1730319252
Payments from drug & device makers
Across 469 payments — averaging $775.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$97K
- M.a. Med Alliance S.A.$97K
- Abbott$58K
- Medtronic$33K
- Philips North America LLC$29K
- CSL Behring$29K
- plus $19K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 25 | $97,427 |
| M.a. Med Alliance S.A. | 17 | $97,310 |
| Abbott | 82 | $58,369 |
| Medtronic(2 entities) | 149 | $33,144 |
| Philips North America LLC | 52 | $29,415 |
| CSL Behring | 12 | $29,000 |
| Pfizer | 7 | $7,705 |
| ZOLL Circulation Inc | 6 | $3,596 |
| Edwards Lifesciences | 29 | $2,757 |
| Boston Scientific | 16 | $1,275 |
| Shockwave Medical, Inc | 14 | $994 |
| Heartflow, Inc. | 3 | $440 |
| Abiomed | 11 | $313 |
| Amgen | 9 | $305 |
| E.r. Squibb & Sons, L.L.C. | 9 | $268 |
| Opsens Inc. | 2 | $169 |
| Alnylam Pharmaceuticals Inc. | 3 | $167 |
| Penumbra, Inc. | 1 | $164 |
| Cordis US CORP. | 1 | $120 |
| Acist Medical Systems, Inc. | 2 | $104 |
| Novo Nordisk | 3 | $68 |
| Merck | 1 | $61 |
| Terumo Medical Corporation | 3 | $59 |
| Teleflex LLC | 4 | $57 |
| Spectrawave, Inc | 1 | $41 |
| GE HealthCare | 1 | $34 |
| Angiodynamics, Inc. | 1 | $34 |
| Biosense Webster, Inc. | 1 | $30 |
| Cathworks, Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $28 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $16 |
How this compares
$363,519 in reported general payments places this provider in the 90th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Temple
- Robert StolerDallas$8.2M
- James ChoiDallas$5.2M
- Srinivasa PotluriPlano$5.1M
- Neal KleimanHouston$4.8M
- Juan GranadaHouston$4.3M
- Ira LieberKingwood$3.3M
- Cara Ann EastDallas$3M
- Abhijeet DhobleHouston$2.7M
- Jeffrey CarrTyler$2.7M
- M Asad KarimMcKinney$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.